The 4th Annual NASH Summit Europe is dedicated to drug development challenges from discovery to late stage clinical development regarding nonalcoholic steatohepatitis (NASH).
The 4th Annual NASH Summit Europe covers topics such as:
- Considerations from European Health Technology Assessment Bodies when assessing the value of medicines for NASH with NICE
- Pharma-physician disconnect in Europe with the EMA
- Regulatory guidance for NASH with compensated cirrhosis with the FDA
